(Q40582627)

21 September 2017

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma (English)

1 reference

21 September 2017

1 reference

1 reference

1 reference

7

Curiel DT

1 reference

21 September 2017

Kanerva A

1

1 reference

21 September 2017

Bauerschmitz GJ

2

1 reference

21 September 2017

Yamamoto M

3

1 reference

21 September 2017

Lam JT

4

1 reference

21 September 2017

Alvarez RD

5

1 reference

21 September 2017

Siegal GP

6

1 reference

21 September 2017

Hemminki A

8

1 reference

21 September 2017

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

552-559

1 reference

21 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302181

21 September 2017

0 references

cites work

Adenoviral gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Adenoviruses in oncology: a viable option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Induction of cyclo-oxygenase-2 in non-small cell lung cancer cells by infection with DeltaE1, DeltaE3 recombinant adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

The E4-6/7 protein functionally compensates for the loss of E1A expression in adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

The plasticity of dendritic cell responses to pathogens and their components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

inferred from DOI database lookup

7 January 2021

based on heuristic

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

inferred from DOI database lookup

7 January 2021

based on heuristic

An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302181

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302181

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference